These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1365 related articles for article (PubMed ID: 30045395)

  • 1. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H; Marinova M
    Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transjugular intrahepatic portosystemic shunt: an update.
    Fidelman N; Kwan SW; LaBerge JM; Gordon RL; Ring EJ; Kerlan RK
    AJR Am J Roentgenol; 2012 Oct; 199(4):746-55. PubMed ID: 22997364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.
    Hung ML; Lee EW
    Clin Liver Dis; 2019 Nov; 23(4):737-754. PubMed ID: 31563220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax.
    LaBerge JM
    Clin Liver Dis; 2006 Aug; 10(3):583-98, ix. PubMed ID: 17162229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving Indications for Tips.
    Smith M; Durham J
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):36-41. PubMed ID: 26997087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
    Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
    Hassoun Z; Pomier-Layrargues G
    Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):1-4. PubMed ID: 15095845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt.
    Patidar KR; Sydnor M; Sanyal AJ
    Clin Liver Dis; 2014 Nov; 18(4):853-76. PubMed ID: 25438287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use and misuse of transjugular intrahepatic portasystemic shunts.
    Sanyal AJ
    Curr Gastroenterol Rep; 2000 Feb; 2(1):61-71. PubMed ID: 10981005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current use of transjugular intrahepatic portosystemic shunts.
    McCashland TM
    Curr Gastroenterol Rep; 2003 Feb; 5(1):31-8. PubMed ID: 12530946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization.
    Chen S; Li X; Wei B; Tong H; Zhang MG; Huang ZY; Cao JW; Tang CW
    Radiology; 2013 Sep; 268(3):900-6. PubMed ID: 23657891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
    Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
    World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt: current status.
    Boyer TD
    Gastroenterology; 2003 May; 124(6):1700-10. PubMed ID: 12761727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
    Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
    [No Abstract]   [Full Text] [Related]  

  • 20. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
    AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.